Drawing for OPKO

USPTO serial 86456085

OPKO

Reviewed by CopyMark Law Group

Reg. 5093546Status 705Renewal
Filing date
Status date
Registration date
Dec 6, 2016
Examiner
MARESCA, MEREDITH Z
Law office
—

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with OPKO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard M. LaBarge

Richard M. LaBarge MARSHALL GERSTEIN & BORUN LLP63RD FL233 S WACKER DRCHICAGO, IL 60606

Goods and services

ClassDescriptionStatusFirst use
001[ chemical preparations for scientific purposes; chemical preparations, namely, diagnostic reagents for scientific or research use ]SECTION 8 - CANCELLED—
005[ diagnostic agents, preparations and substances for medical purposes; ] pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treating diseases and disorders of the parathyroid, and for treating secondary hyper-parathyroidism; pharmaceutical preparations for the treatment of vitamin D deficiency [ ; pharmaceutical preparations for use in renal dialysis and in the treatment of renal diseases and kidney ailments; pharmaceutical preparations in the nature of phosphate binders for use in the treatment of hyperphosphataemial; human growth hormone; medical diagnostic kits comprised of medical diagnostic reagents and assays for testing body fluids ]ACTIVE—
009[ computer software for analyzing medical test results, the software relating to the scientific, pharmaceutical, genetic, medical and medical diagnostic fields; computer software for operating medical diagnostic apparatus, the software relating to at least one of the scientific, pharmaceutical, genetic, medical and medical diagnostic fields ]SECTION 8 - CANCELLED—
010[ in-vitro diagnostic testing medical instruments for testing blood and other bodily fluids and tissues; medical instruments for use in monitoring the content of bodily fluids; medical apparatus for testing for the presence of particular substances in blood; medical devices for detecting cancer; medical devices for diagnosing vitamin D deficiencies; medical diagnostic apparatus in the nature of a diagnostic card containing medical diagnostic reagents and immunoassays sold together as a kit for at least one of the following: testing body fluids, diagnosing urological disease, kidney disease, cancer, and vitamin deficiencies ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 6, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 8, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 8, 2023C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 8, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 6, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Dec 6, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 6, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 20, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 20, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 31, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 18, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 12, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 12, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Aug 12, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 12, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 12, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 5, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 5, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 29, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 10, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 8, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 8, 2016ALIEASSIGNED TO LIE—
Feb 1, 2016ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 17, 2015GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Dec 17, 2015GNSIINQUIRY TO SUSPENSION E-MAILED—
Dec 17, 2015CNSISUSPENSION INQUIRY WRITTEN—
Jun 17, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 17, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Jun 17, 2015CNSLSUSPENSION LETTER WRITTEN—
Jun 16, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 15, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 15, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 17, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 17, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 17, 2014DOCKASSIGNED TO EXAMINER—
Nov 24, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 20, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance